A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 variants, current vaccines show decreased neutra...
Main Authors: | Naru Zhang, Kangchen Li, Zezhong Liu, Kutty Selva Nandakumar, Shibo Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/2/387 |
Similar Items
-
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
by: Naru Zhang, et al.
Published: (2022-02-01) -
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01) -
The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus
by: Gabriela Brzuska, et al.
Published: (2023-06-01) -
Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
by: Juan Shi, et al.
Published: (2023-03-01) -
Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines
by: Mohamed Ahmed Attia, et al.
Published: (2021-11-01)